Trial Information
Pharmacological Modulation of the Intrarenal Pressure During Endourological Procedures in the Upper Urinary Tract
Inclusion Criteria:
- Indication for ureterorenoscopy
- Age> 18 years
- Normal blood pressure
Exclusion Criteria:
- Malignant disease in the upper urinary tract
- Heart disease
- Allergy to Isoproterenol
- Use of α-blocking or β-blocking medicine
- Use of Calcium-antagonists
- Use of NSAIDs the last 48 hours
- Present stone or JJ-stent in the ureter
- Neurologic disease in the bladder
- Pregnancy
- Nursing mothers
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
pelvic pressure
Principal Investigator
Palle JS Osther, PhD, MD
Investigator Role:
Study Director
Investigator Affiliation:
Dp. of Urology, Fredericia & Kolding Hospitals, Fredericia, denmark
Authority:
Denmark: Danish Medicines Agency
Study ID:
HJ2
NCT ID:
NCT00428428
Start Date:
February 2007
Completion Date:
November 2007
Related Keywords:
- Kidney Stone
- Unexplained Haematuria
- Benignant Tumour Mass in the Upper Urinary Tract
- kidney stone
- ureteroscopy
- Hematuria
- Kidney Calculi
- Nephrolithiasis